Search results
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 3 hours agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, ...
BIIB INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with...
Benzinga· 1 day agoSAN DIEGO, June 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Biogen Inc. (NASDAQ:BIIB) securities between February 3, 2022 and February 13, 2024, both
Is Biogen Inc.'s (NASDAQ:BIIB) Recent Price Movement Underpinned By Its Weak Fundamentals?
Simply Wall St. via Yahoo Finance· 6 days agoIt is hard to get excited after looking at Biogen's (NASDAQ:BIIB) recent performance, when its stock...
... Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Biogen...
Morningstar· 4 days agoLaw Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB
BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law...
Benzinga· 2 days agoNEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (NASDAQ:BIIB) Securities Class Action Lawsuit. If you
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance· 3 days agoBiogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...
RBC maintains $317 price target on Biogen stock, cites Skyclarys importance By Investing.com
Investing.com· 5 days agoOn Wednesday, RBC (TSX:RY) Capital maintained its Outperform rating on Biogen (NASDAQ:BIIB) shares...
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Benzinga via Yahoo Finance· 3 days agoOn Thursday, the European Commission granted marketing authorization under exceptional circumstances...
...Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the...
Benzinga· 2 days agoBragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") ...
European Commission grants marketing approval to Biogen's ALS drug
Reuters· 4 days ago, opens new tab said on Thursday that the European Commission has granted marketing authorization...